China punishes pharmaceutical supplier for abuse of dominance
China’s competition watchdog has ordered one of the country’s largest suppliers of active pharmaceutical ingredients to pay over €1.4 million for imposing excessive prices on drug manufacturers from 2014 to 2017.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10